<link rel="stylesheet" href="/res/styles.39be4579664c3a48.css">
Artículo

Development of Nanobody-Displayed Whole-Cell Biosensors for the Colorimetric Detection of SARS-CoV-2

He, Yawen ; Xu, Zhiyuan ; Kasputis, Tom ; Zhao, Xue ; Ibañez, Lorena Itatí Icon; Pavan, Maria Florencia Icon; Bok, Marina Icon; Malito, Juan Pablo Alfonso ; Parreno, Viviana ; Yuan, Lijuan ; Wright, R. Clay ; Chen, Juhong

Otros responsables

Fecha

08/2023

Editorial

American Chemical Society

Revista

ACS Applied Materials & Interfaces

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

1944-8244

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Clasificación temática

Resumen

The accurate and effective detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential to preventing the spread of infectious diseases and ensuring human health. Herein, a nanobody-displayed whole-cell biosensor was developed for colorimetric detection of SARS-CoV-2 spike proteins. Serving as bioreceptors, yeast surfaces were genetically engineered to display SARS-CoV-2 binding of llama-derived single-domain antibodies (nanobodies) with high capture efficiency, facilitating the concentration and purification of SARS-CoV-2. Gold nanoparticles (AuNPs) employed as signal transductions were functionalized with horseradish peroxidase (HRP) and anti-SARS monoclonal antibodies to enhance the detection sensitivity. In the presence of SARS-CoV-2 spike proteins, the sandwiched binding will be formed by linking engineered yeast, SARS-CoV-2 spike proteins, and reporter AuNPs. The colorimetric signal was generated by the enzymatic reaction of HRP and its corresponding colorimetric substrate/chromogen system. At the optimal conditions, the developed whole-cell biosensor enables the sensitive detection of SARS-CoV-2 spike proteins in a linear range from 0.01 to 1 μg/mL with a limit of detection (LOD) of 0.037 μg/mL (about 4 × 108 virion particles/mL). Furthermore, the whole-cell biosensor was demonstrated to detect the spike protein of different SARS-CoV-2 variants in human serum, providing new possibilities for the detection of future SARS-CoV-2 variants.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa